ISSN: 2640-2637
Authors: Mistrih FG, Mistrih NG and Eghon G*
In a market in Wuhan, China, apparently due to the ingestion of live bats, as part of the culture of the natives, an infection of the virus was generated, which until now has not been effectively treated, which is why we justify expanding our knowledge of a therapeutic alternative that appears, beyond being a preventive treatment, perhaps the solution to this pandemic, the effectiveness of IV mesenchymal cell transplantation, has not been described with conclusive results that allow scientists to propose it as the only treatment, but studies in multiple pathologies show a very favorable immune reaction, modulating inflammatory cascades in inflamed tissues. In addition, it clearly presents a regeneration of it (which is the same) that has powerfully caught the attention of doctors when treating pathologies, autoimmune, degenerative, and chronic pathologies, which to date have had no palliative treatments, such as SLE, post-infarction heart disease, chronic arthritis, Alzheimer’s and among others, many laboratory studies were necessary, due to the urgent need of frustrated patients due to the few therapeutic possibilities that led to the use of mesenchymal cells for their treatment. The pneumonias caused by this new virus are of rapid progression and very lethal, with a treatment of little effectiveness and for this reason we have proposed the regulation of cytosines through the transplantation of mesenchymal cells, being these the main causes of complications due to their increase in the systemic reaction.
Keywords: Covid-19; Tissues; Receptor Bindings; Enzymes
